Godshalk Welsh Capital Management, Inc. - Q4 2019 holdings

$121 Million is the total value of Godshalk Welsh Capital Management, Inc.'s 112 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 14.8% .

 Value Shares↓ Weighting
BRKB BuyBerkshire Hathaway Inc Cl B$2,850,000
+9.5%
12,583
+0.6%
2.35%
+2.1%
PGX BuyInvesco Preferredetf$2,165,000
+9.5%
144,258
+9.6%
1.78%
+2.1%
CSCO BuyCisco Systems Inc$2,145,000
-2.9%
44,727
+0.1%
1.77%
-9.5%
JNJ BuyJohnson & Johnson$2,054,000
+13.5%
14,081
+0.7%
1.69%
+5.9%
ORCL BuyOracle Corp$1,946,000
-0.7%
36,735
+3.2%
1.60%
-7.4%
COP BuyConocoPhillips$1,508,000
+14.2%
23,195
+0.1%
1.24%
+6.5%
IEFA BuyiShares Core MSCI EAFEetf$1,427,000
+32.0%
21,875
+23.6%
1.18%
+23.0%
T BuyA T & T$1,346,000
+5.9%
34,437
+2.5%
1.11%
-1.2%
BIV BuyVgd Int Term Bond Index Fundetf$1,248,000
+5.0%
14,310
+5.9%
1.03%
-2.2%
GSK BuyGlaxoSmithKline PLC ADRadr$1,142,000
+10.6%
24,300
+0.4%
0.94%
+3.1%
BSV BuyVanguard Short Term Bond Indexetf$1,127,000
+12.0%
13,975
+12.2%
0.93%
+4.5%
PFE BuyPfizer Inc$1,070,000
+9.6%
27,303
+0.6%
0.88%
+2.2%
RSP BuyInvesco S&P 500 Eq Wtetf$943,000
+25.1%
8,150
+16.8%
0.78%
+16.7%
TJX BuyTJX Companies Inc$841,000
+10.4%
13,775
+0.7%
0.69%
+2.8%
CMCSA BuyComcast Corp Class A$841,000
+4.9%
18,700
+5.1%
0.69%
-2.3%
CVS BuyCVS Health Corporation$834,000
+38.3%
11,225
+17.5%
0.69%
+28.9%
VLO BuyValero Energy Corp$805,000
+17.3%
8,600
+6.8%
0.66%
+9.4%
CL BuyColgate-Palmolive Co$688,000
-5.0%
10,000
+1.5%
0.57%
-11.4%
DD BuyDuPont de Nemours Inc$580,000
+38.4%
9,038
+53.8%
0.48%
+29.2%
C BuyCitigroup Inc$565,000
+16.5%
7,075
+0.7%
0.47%
+8.6%
UNF BuyUniFirst Corp$530,000
+7.5%
2,625
+4.0%
0.44%
+0.2%
EEMV BuyiShares MSCI EmergMkt Min Voletf$510,000
+15.4%
8,700
+12.3%
0.42%
+7.4%
IFF BuyIntl Flavors & Fragrances$506,000
+10.5%
3,920
+5.0%
0.42%
+3.0%
UGI BuyUGI Corporation$441,000
+32.8%
9,760
+47.7%
0.36%
+23.9%
BMY BuyBristol-Myers Squibb Co$385,000
+61.8%
6,000
+27.7%
0.32%
+51.0%
EFA BuyiShares MSCI EAFE Indexetf$330,000
+12.6%
4,750
+5.6%
0.27%
+5.0%
AOM BuyiShares Core Moderate Allocatietf$283,000
+38.7%
7,050
+35.6%
0.23%
+29.4%
ANTM NewAnthem Inc$216,000715
+100.0%
0.18%
AOR NewiShares Core Growth Allocationetf$215,0004,502
+100.0%
0.18%
IUSG NewiShares Core S&P US Growthetf$210,0003,100
+100.0%
0.17%
HON NewHoneywell International Inc$204,0001,150
+100.0%
0.17%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-02-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Microsoft Corporation36Q3 20236.7%
Globus Medical Inc36Q3 20234.9%
Intuit Inc36Q3 20233.7%
Costco Wholesale Corp36Q3 20233.0%
Procter & Gamble36Q3 20232.3%
iShares Russell 2000 Index36Q3 20232.2%
Merck & Co36Q3 20232.4%
Johnson & Johnson36Q3 20232.2%
Oracle Corp36Q3 20232.9%
Paychex Inc36Q3 20231.9%

View Godshalk Welsh Capital Management, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-15
13F-HR2024-02-12
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-10
13F-HR2022-05-12
13F-HR2022-02-14

View Godshalk Welsh Capital Management, Inc.'s complete filings history.

Compare quarters

Export Godshalk Welsh Capital Management, Inc.'s holdings